Zobrazeno 1 - 10
of 1 450
pro vyhledávání: '"G, Bader"'
Autor:
Swati Shetty, Kyle MacDonald, Sailaja Pirati, Sadhak Sengupta, Heather L MacGregor, Suzanna L Prosser, Stacey X Xu, Aksha Kadri, Ritu R Randhawa, Deepika Bhemarasetty, Christopher W Helsen, Andreas G Bader
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0e3a21cc97fe467683fcfee55a304f2a
Autor:
Ling Wang, Kyle MacDonald, Sailaja Pirati, Sadhak Sengupta, Suzanna L Prosser, Stacey X Xu, Ritu R Randhawa, Deepika Bhemarasetty, Christopher W Helsen, Andreas G Bader, Seung Mi Yoo, Miyoung E Jung, Laurentia A Gheorghiu, Chris L Ayers
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9e5a12f06bf341938e447d8e3a17fcf4
Autor:
Tania Benatar, Thanyashanthi Nitya-Nootan, Prabha Lal, Philbert Ip, Sailaja Pirati, Suzanna L Prosser, Stacey X Xu, Deepika Bhemarasetty, Christopher W Helsen, Andreas G Bader, Gargi Thakor, Alima Khan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/4330629331f54d5b87c29765b4492a63
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Reham M. Dawood, Rehab I. Moustafa, Tawfeek H. Abdelhafez, Reem El-Shenawy, Yasmine El-Abd, Noha G. Bader El Din, Jean Dubuisson, Mostafa K. El Awady
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Although DAAs hold promise to significantly reduce rates of chronic HCV infections, its eradication still requires development of an effective vaccine. Prolonged T cell responses and cross neutralizing antibodies are ideal for vac
Externí odkaz:
https://doaj.org/article/748e9457195c4bdeb0a07100b62830d4
Autor:
Ksenia Bezverbnaya, Joanne A. Hammill, Derek Cummings, Bojana Bojovic, Bella Groisman, Christopher L. Baker, Craig Aarts, Danielle L. Hayes, Donna Rill, Stacey X. Xu, Andreas G. Bader, Christopher W. Helsen, Jonathan L. Bramson
Publikováno v:
Cytotherapy. 25:490-501
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::547661220b61c9473b056e6d54a5f9f5
https://doi.org/10.1016/j.jcyt.2023.01.002
https://doi.org/10.1016/j.jcyt.2023.01.002
Publikováno v:
Biomarkers in Medicine. 17:159-169
Background: The key role of miRNA expression in incidence and progression of colorectal cancer (CLC) have been developed over the last decade. Materials & methods: A total of 153 subjects were enrolled into two phases: 14 selected miRNAs were first e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::771cee2ae562c88162b9a0f1ccdc7436
https://doi.org/10.2217/bmm-2022-0861
https://doi.org/10.2217/bmm-2022-0861
Autor:
Ayman Yosry, Naglaa Zayed, Reham M Dawood, Marwa K Ibrahim, Marwa Elsharkawy, Sherif M Ekladious, Ahmed Khairy, Aisha Elsharkawy, Marwa Khairy, Shereen Abdel Alem, Noha G Bader El Din, Mostafa K El Awady, Zeinab Abdellatif
Publikováno v:
Laboratory Medicine. 53:523-529
Objective This study aimed at exploring the potential role of a panel of serum micro-RNA (miRNA) markers in liver fibrosis and hepatocellular carcinoma (HCC) diagnosis in patients with chronic hepatitis C virus (HCV) infection. Methods The study incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c761c325a9578336f4dbe1608780c9d
https://doi.org/10.1093/labmed/lmac045
https://doi.org/10.1093/labmed/lmac045
Autor:
Andreas G. Bader, David Brown, Lubna Patrawala, Michael Omotola, Kevin Kelnar, Lynnsie Ruffino, Jason F. Wiggins
Supplementary Table 1 from Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655a8a2534b5514cbc4b7e05f093429c
https://doi.org/10.1158/0008-5472.22382700
https://doi.org/10.1158/0008-5472.22382700
Autor:
Andreas G. Bader, David Brown, Lubna Patrawala, Michael Omotola, Kevin Kelnar, Lynnsie Ruffino, Jason F. Wiggins
Supplementary Figures 1-6 from Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372c30b066ad50a306d7f291bdb4f28b
https://doi.org/10.1158/0008-5472.22382706.v1
https://doi.org/10.1158/0008-5472.22382706.v1